Wellington Management Group LLP Sage Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$548 Billion
Q2 2024

A detailed history of Wellington Management Group LLP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 39,645 shares of SAGE stock, worth $289,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,645

Previous 4,752,197 99.17%

Holding current value

$289,012

Previous $89.1 Million 99.52%

% of portfolio

0.0%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$10.58 - $17.9 $49.9 Million - $84.4 Million	-4,712,552 Reduced 99.17%	39,645 $430,000
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $88.5 Million - $128 Million	4,752,197 New	4,752,197 $89.1 Million
Q4 2023 Feb 12, 2024	BUY	$17.1 - $22.26 $104 Million - $135 Million	6,061,996 New	6,061,996 $131 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $3.49 Million - $10.2 Million	208,630 Added 3.28%	6,572,260 $135 Million
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $26.4 Million - $38.7 Million	649,207 Added 11.36%	6,363,630 $299 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $7.39 Million - $9.23 Million	198,287 Added 3.59%	5,714,423 $240 Million
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $18.8 Million - $25.5 Million	583,618 Added 11.83%	5,516,136 $210 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $5.9 Million - $7.91 Million	182,895 Added 3.85%	4,932,518 $193 Million
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $61.8 Million - $85.3 Million	-2,245,377 Reduced 32.1%	4,749,623 $153 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $4.04 Million - $6.01 Million	-131,411 Reduced 1.84%	6,995,000 $232 Million
Q4 2021 Feb 11, 2022	BUY	$37.06 - $47.11 $13.2 Million - $16.8 Million	356,478 Added 5.27%	7,126,411 $303 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $38.6 Million - $55 Million	957,993 Added 16.48%	6,769,933 $300 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $35.5 Million - $51.2 Million	646,151 Added 12.51%	5,811,940 $330 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $62.3 Million - $85.4 Million	882,160 Added 20.59%	5,165,789 $387 Million
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $236 Million - $360 Million	4,045,121 Added 1696.01%	4,283,629 $371 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $3.87 Million - $5.88 Million	94,161 Added 65.23%	238,508 $14.6 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $3.75 Million - $6.23 Million	144,347 New	144,347 $6 Million
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $25.5 Million - $75.4 Million	-975,613 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$60.18 - $154.77 $58.7 Million - $151 Million	975,613 New	975,613 $70.4 Million

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

48.2M

Call Options Held

854K

Put Options Held

195K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $433M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Sage Therapeutics, Inc. Transaction History